Live catalyst feed

Tuesday, October 6, 2026

Every market-moving event Day Trader Sniper classified this session, with HCS category, session chart, and observed market response. Not financial advice.

←→Jump to latest

Regulatory and ClinicalDSMB Efficacy MetOct 6, 2026 · 7:30am ET

KAPAKairos Pharma, LTD.

Kairos Pharma Reports Positive Interim Efficacy Data from Phase 2 Trial of ENV-105

Company announced statistically significant results in metastatic prostate cancer treatment.

Regulatory and ClinicalDSMB Efficacy MetOct 6, 2026 · 7:30am ET

KAPAKairos Pharma, LTD.+38.0%

Kairos Pharma Reports Positive Interim Efficacy Data from Phase 2 Trial of ENV-105

Be early on the next spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →